Epilepsi

Scope & Guideline

Elevating the conversation around epilepsy through open access.

Introduction

Delve into the academic richness of Epilepsi with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN1300-7157
PublisherKARE PUBL
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEPILEPSI / Epilepsi
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGoztepe Mah. Fahrettin Kerim Gokay Caddesi. No: 200/A D:2 Cemenzar - Kadkoy, ISTANBUL 34720, Turkiye

Aims and Scopes

The journal 'Epilepsi' is dedicated to advancing the understanding and management of epilepsy through a multifaceted approach that encompasses clinical, neurophysiological, and psychological aspects of the condition. It serves as a platform for disseminating innovative research and clinical findings that enhance the quality of care for individuals affected by epilepsy.
  1. Clinical Research on Epilepsy:
    The journal focuses on clinical studies that investigate various aspects of epilepsy, including diagnosis, treatment, and management strategies for different patient populations.
  2. Neurophysiological Studies:
    Research highlighting neurophysiological mechanisms underlying epilepsy, such as electroencephalography (EEG) findings and their implications for seizure classification and management.
  3. Impact of Comorbidities:
    Exploration of how comorbid conditions, such as mental health disorders and autoimmune diseases, interact with epilepsy and affect patient outcomes.
  4. Innovative Therapies and Interventions:
    Studies assessing the efficacy and safety of novel treatments, including pharmacological therapies, surgical approaches, and neuromodulation techniques like vagus nerve stimulation.
  5. Quality of Life and Patient Experience:
    Research examining the psychosocial impact of epilepsy on patients and their families, including quality of life assessments and the effects of seizures on daily living.
Recent publications in 'Epilepsi' indicate a dynamic shift towards emerging themes that address contemporary issues in epilepsy research, particularly those influenced by global health events and advancements in technology.
  1. Impact of COVID-19 on Epilepsy Care:
    A significant trend has emerged in studying the effects of the COVID-19 pandemic on epilepsy patients, including changes in seizure frequency, quality of life, and mental health outcomes, highlighting the need for adaptive care strategies.
  2. Genetic and Molecular Insights:
    Increasing focus on genetic factors and molecular mechanisms associated with epilepsy, including studies on specific mutations and their implications for personalized treatment approaches.
  3. Psychosocial Dimensions of Epilepsy:
    Growing attention towards the psychosocial aspects of living with epilepsy, including patient education, stigma, and the role of family dynamics, indicating a broader understanding of patient care.
  4. Neuroimaging and Advanced Diagnostics:
    Emerging themes around the use of advanced neuroimaging techniques to better understand brain alterations in epilepsy, which may lead to improved diagnostic accuracy and treatment planning.
  5. Integration of Technology in Management:
    The rise of digital health technologies, such as mobile applications for seizure tracking and telemedicine, reflects a trend towards innovative solutions in epilepsy management and patient engagement.

Declining or Waning

As the field of epilepsy research evolves, certain themes have become less prominent in recent publications. This decline may reflect shifts in research priorities or advancements in understanding that render some topics less relevant.
  1. Historical Case Studies:
    There has been a noticeable reduction in the publication of historical case studies, perhaps due to a growing emphasis on contemporary research methodologies and larger cohort studies.
  2. Basic Science Research:
    While foundational research remains important, the frequency of studies focusing solely on basic science aspects of epilepsy without clinical application has decreased, as journals prioritize translational research that bridges lab findings with clinical practice.
  3. Traditional Pharmacological Approaches:
    Research focusing on established antiepileptic drugs without exploring new therapeutic avenues or adjunctive treatments has waned, reflecting a shift towards innovative solutions for drug-resistant epilepsy.

Similar Journals

Archives of Epilepsy

Empowering knowledge in the fight against epilepsy.
Publisher: GALENOS PUBL HOUSEISSN: Frequency: 4 issues/year

Archives of Epilepsy is a pioneering academic journal dedicated to advancing the field of epilepsy research and clinical practice. Published by GALENOS PUBL HOUSE in Turkey, this Open Access journal has embraced the principle of unrestricted access since its inception in 2012, allowing researchers, healthcare professionals, and students from around the world to engage with cutting-edge findings in neuropathology. With a focus on clinical and neuroscience aspects of neurology, the journal occupies a significant position in the academic landscape, currently ranked in the Q4 quartile in both Neurology and Clinical Neurology categories as of 2023. Though it faces challenges in its Scopus rankings with a current percentile of 2nd in Medicine - Neurology (Clinical) and 1st in Neuroscience - Neurology, it offers a valuable platform for emerging studies. The journal's commitment to fostering a comprehensive understanding of epilepsy is crucial, as it facilitates broader discourse on effective treatments and patient care strategies. We invite researchers and practitioners to explore the impactful articles published in the Archives of Epilepsy and contribute to an evolving dialogue that strives to improve outcomes for individuals affected by epilepsy.

Journal of Pediatric Epilepsy

Advancing knowledge for brighter futures in pediatric epilepsy.
Publisher: GEORG THIEME VERLAG KGISSN: 2146-457XFrequency: 4 issues/year

The Journal of Pediatric Epilepsy, published by GEORG THIEME VERLAG KG, is a dedicated platform for advancing the understanding and treatment of pediatric epilepsy. With ISSN 2146-457X and E-ISSN 2146-4588, this journal provides vital insights and research findings relevant to clinicians, researchers, and students in the fields of neurology, pediatrics, and psychiatry. Although its coverage in Scopus was discontinued from 2012 to 2015, the journal continues to contribute to the body of knowledge within this critical area by focusing on novel therapeutic strategies, clinical studies, and case reports that address the unique challenges faced by children with epilepsy. The journal is committed to fostering collaboration and innovation in the treatment of pediatric seizure disorders, making it an essential resource for anyone dedicated to improving outcomes in this vulnerable population.

Cancer Management and Research

Transforming cancer care with groundbreaking insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Current Journal of Neurology

Pioneering the future of neurological research and treatment.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Agri-The Journal of the Turkish Society of Algology

Empowering Clinicians with Cutting-Edge Insights
Publisher: KARE PUBLISSN: 1300-0012Frequency: 4 issues/year

Agri - The Journal of the Turkish Society of Algology, published by KARE PUBL, is a significant academic platform dedicated to advancing the field of anesthesiology and pain medicine. Established in 1993, this journal has made substantial contributions towards understanding pain management strategies and therapeutic interventions in the medical community in Turkey and beyond. With an impact factor reflecting its Q3 category ranking within Anesthesiology and Pain Medicine and a respectable Scopus rank of 93 out of 136, it provides critical insights and research findings that are instrumental for both clinicians and researchers alike. The journal operates under an open access model, which enhances the visibility and accessibility of valuable research outputs for a global audience. An essential resource for professionals in pain management, Agri encourages the exchange of innovative ideas and groundbreaking studies within this vital area of medicine.

Iraqi Journal of Hematology

Innovative Insights for Blood Health
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2072-8069Frequency: 2 issues/year

Iraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.

KLINISCHE NEUROPHYSIOLOGIE

Advancing the frontiers of clinical neurophysiology.
Publisher: GEORG THIEME VERLAG KGISSN: 1434-0275Frequency: 4 issues/year

KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Elevating understanding of epilepsy through research.
Publisher: W B SAUNDERS CO LTDISSN: 1059-1311Frequency: 10 issues/year

SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

ESMO Open

Fostering global collaboration in oncology research.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

ESMO Open is a premier open-access journal published by Elsevier, dedicated to advancing research in the fields of cancer and oncology. Since its inception in 2016, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals, providing a platform for disseminating high-quality, peer-reviewed research. With an impressive Q1 ranking in both Cancer Research and Oncology based on the 2023 category quartiles, ESMO Open ranks within the top tier of its field, showcasing its commitment to excellence and innovation. The journal’s inclusion in Scopus rankings further emphasizes its significant impact, with remarkable placements in the 88th and 83rd percentiles for Oncology and Cancer Research, respectively. Operating under an open access model, ESMO Open ensures that cutting-edge findings and insights are readily available to the global academic community, fostering collaboration and knowledge-sharing to further enhance the understanding and treatment of cancer.

Therapeutic Advances in Neurological Disorders

Connecting researchers and practitioners in the realm of neurology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-2856Frequency: 1 issue/year

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.